The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Panic Disorders-Global Market Insights and Sales Trends 2024
Synopsis
Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.
The global Panic Disorders market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Panic Disorders in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Drug Stores and E-Commerce, are propelling Panic Disorders market. Anti-Depressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzodiazepines segment is estimated at % CAGR for the next seven-year period.
Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used include antidepressants and occasionally benzodiazepines or beta blockers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Panic Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Panic Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Panic Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Panic Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Panic Disorders covered in this report include Teva Pharmaceutical, Sun Pharmaceuticals, Mylan and AstraZeneca, etc.
The global Panic Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical
Sun Pharmaceuticals
Mylan
AstraZeneca
Global Panic Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Panic Disorders market, Segment by Type:
Anti-Depressants
Benzodiazepines
Global Panic Disorders market, by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Panic Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.
The global Panic Disorders market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Panic Disorders in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Drug Stores and E-Commerce, are propelling Panic Disorders market. Anti-Depressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Benzodiazepines segment is estimated at % CAGR for the next seven-year period.
Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used include antidepressants and occasionally benzodiazepines or beta blockers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Panic Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Panic Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Panic Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Panic Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Panic Disorders covered in this report include Teva Pharmaceutical, Sun Pharmaceuticals, Mylan and AstraZeneca, etc.
The global Panic Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical
Sun Pharmaceuticals
Mylan
AstraZeneca
Global Panic Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Panic Disorders market, Segment by Type:
Anti-Depressants
Benzodiazepines
Global Panic Disorders market, by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-Commerce
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Panic Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Panic Disorders
1.1 Panic Disorders Market Overview
1.1.1 Panic Disorders Product Scope
1.1.2 Panic Disorders Market Status and Outlook
1.2 Global Panic Disorders Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Panic Disorders Market Size by Region (2018-2029)
1.4 Global Panic Disorders Historic Market Size by Region (2018-2023)
1.5 Global Panic Disorders Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Panic Disorders Market Size (2018-2029)
1.6.1 North America Panic Disorders Market Size (2018-2029)
1.6.2 Europe Panic Disorders Market Size (2018-2029)
1.6.3 Asia-Pacific Panic Disorders Market Size (2018-2029)
1.6.4 Latin America Panic Disorders Market Size (2018-2029)
1.6.5 Middle East & Africa Panic Disorders Market Size (2018-2029)
2 Panic Disorders Market by Type
2.1 Introduction
2.1.1 Anti-Depressants
2.1.2 Benzodiazepines
2.2 Global Panic Disorders Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Panic Disorders Historic Market Size by Type (2018-2023)
2.2.2 Global Panic Disorders Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Panic Disorders Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Panic Disorders Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Panic Disorders Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Panic Disorders Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Panic Disorders Revenue Breakdown by Type (2018-2029)
3 Panic Disorders Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Drug Stores
3.1.4 E-Commerce
3.2 Global Panic Disorders Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Panic Disorders Historic Market Size by Application (2018-2023)
3.2.2 Global Panic Disorders Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Panic Disorders Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Panic Disorders Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Panic Disorders Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Panic Disorders Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Panic Disorders Revenue Breakdown by Application (2018-2029)
4 Panic Disorders Competition Analysis by Players
4.1 Global Panic Disorders Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Panic Disorders as of 2022)
4.3 Date of Key Players Enter into Panic Disorders Market
4.4 Global Top Players Panic Disorders Headquarters and Area Served
4.5 Key Players Panic Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Panic Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva Pharmaceutical
5.1.1 Teva Pharmaceutical Profile
5.1.2 Teva Pharmaceutical Main Business
5.1.3 Teva Pharmaceutical Panic Disorders Products, Services and Solutions
5.1.4 Teva Pharmaceutical Panic Disorders Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Pharmaceutical Recent Developments
5.2 Sun Pharmaceuticals
5.2.1 Sun Pharmaceuticals Profile
5.2.2 Sun Pharmaceuticals Main Business
5.2.3 Sun Pharmaceuticals Panic Disorders Products, Services and Solutions
5.2.4 Sun Pharmaceuticals Panic Disorders Revenue (US$ Million) & (2018-2023)
5.2.5 Sun Pharmaceuticals Recent Developments
5.3 Mylan
5.3.1 Mylan Profile
5.3.2 Mylan Main Business
5.3.3 Mylan Panic Disorders Products, Services and Solutions
5.3.4 Mylan Panic Disorders Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Panic Disorders Products, Services and Solutions
5.4.4 AstraZeneca Panic Disorders Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
6 North America
6.1 North America Panic Disorders Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Panic Disorders Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Panic Disorders Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Panic Disorders Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Panic Disorders Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Panic Disorders Market Dynamics
11.1 Panic Disorders Industry Trends
11.2 Panic Disorders Market Drivers
11.3 Panic Disorders Market Challenges
11.4 Panic Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
